Global Custom Market Research Reports Provider Company

phone

Immune Pharmaceuticals Inc (IMNP) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a biotechnology company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The companys bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohns disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharmas crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.

Immune Pharmaceuticals Inc Key Recent Developments

Dec 11,2017: Immune Pharmaceuticals Appoints John Zhang, MD, PhD as Vice President, Research and Development
Nov 27,2017: Immune Provides Update Regarding NASDAQ US Listing and Departure of Officer
Nov 15,2017: Immune Pharmaceuticals Announces Third Quarter 2017 Financial Results and Provides a Corporate Update
Aug 28,2017: Immune Pharmaceuticals Provides Business Update and Summary of Recent Financial Highlights
Aug 14,2017: Immune Pharmaceuticals appoints Tony Fiorino, MD, PhD as Chief Medical Officer and Chief Operating Officer

This comprehensive SWOT profile of Immune Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immune Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Immune Pharmaceuticals Inc - Key Information
Immune Pharmaceuticals Inc - Overview
Immune Pharmaceuticals Inc - Key Employees
Immune Pharmaceuticals Inc - Key Employee Biographies
Immune Pharmaceuticals Inc - Key Operational Heads
Immune Pharmaceuticals Inc - Major Products and Services
Immune Pharmaceuticals Inc - History
Immune Pharmaceuticals Inc - Company Statement
Immune Pharmaceuticals Inc - Locations And Subsidiaries
Immune Pharmaceuticals Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Immune Pharmaceuticals Inc - Business Description
Immune Pharmaceuticals Inc - Corporate Strategy
Immune Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Immune Pharmaceuticals Inc - Strengths
Immune Pharmaceuticals Inc - Weaknesses
Immune Pharmaceuticals Inc - Opportunities
Immune Pharmaceuticals Inc - Threats
Immune Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Immune Pharmaceuticals Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Immune Pharmaceuticals Inc, Key Information
Immune Pharmaceuticals Inc, Key Ratios
Immune Pharmaceuticals Inc, Share Data
Immune Pharmaceuticals Inc, Major Products and Services
Immune Pharmaceuticals Inc, History
Immune Pharmaceuticals Inc, Key Employees
Immune Pharmaceuticals Inc, Key Employee Biographies
Immune Pharmaceuticals Inc, Key Operational Heads
Immune Pharmaceuticals Inc, Other Locations
Immune Pharmaceuticals Inc, Subsidiaries
Immune Pharmaceuticals Inc, Key Manufacturing facilities
Immune Pharmaceuticals Inc, Key Competitors
Immune Pharmaceuticals Inc, SWOT Analysis
Immune Pharmaceuticals Inc, Ratios based on current share price
Immune Pharmaceuticals Inc, Annual Ratios
Immune Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Immune Pharmaceuticals Inc, Performance Chart
Immune Pharmaceuticals Inc, Ratio Charts

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline Cancer immunotherapy, which can predominantly be classed as a form

View Report

Primary Immune Deficiency (PID) Global Clinical Trials Review, H1, 2018 GlobalDatas clinical trial report, Primary Immune Deficiency (PID) Global Clinical Trials Review, H1, 2018 provides an overview of Primary Immune Deficiency

View Report

AC Immune SA (ACIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports